Clinical Trials Browser

Adenocarcinoma, Carcinoma, Adenocarcinoma, Mucinous, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms, Neoplasms, Cystic, Mucinous, and Serous

NCT03591666 2018-07-19

A Study of Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas

Phase 2 Unknown

51 enrolled

Adenocarcinoma, Recurrence

NCT03402464 2018-01-18

Icotinib Combined With Dihydroaremisinin (DHA) Therapy in Patients With Advanced NSCLC

Phase 2 Unknown

30 enrolled

Tumor-Agnostic

Adenocarcinoma

NCT01952951 2017-09-13

PREPARE

Phase 2 Unknown

110 enrolled

Gastrointestinal

Adenocarcinoma, Rectal Neoplasms

NCT01930864 2017-06-22

Metformin Plus Irinotecan for Refractory Colorectal Cancer

Phase 2 Unknown

41 enrolled

Gastrointestinal

Adenocarcinoma, Colorectal Neoplasms

NCT02951637 2016-11-01

Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial

Phase 2 Unknown

300 enrolled

Thoracic

Adenocarcinoma of Lung, Adenocarcinoma

NCT01502202 2012-06-20

Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers

Phase 2 Unknown

162 enrolled

Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Carcinoma, Non-Small-Cell Lung

NCT01556815 2012-04-25

Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma

Phase 2 Unknown

40 enrolled

Gastrointestinal

Adenocarcinoma, Carcinoma, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

NCT01552967 2012-03-28